News
FDA does a 180, suspending use of Valneva's chikungunya vaccine
Less than three weeks after lifting a pause on the use of Valneva’s chikungunya vaccine Ixchiq, the FDA has done an about-face, banning the use of the shot in the United States. | Less than three weeks after lifting a pause on the use of Valneva’s chikungunya vaccine Ixchiq,
The recalls have been classified as Class II, where the probability of serious adverse health consequences is remote.
WISH-TV on MSN3m
FDA-approved semaglutide aids weight loss and health conditions
Learn about the use of GLP-1 agonists for weight loss and health improvement by celebrities like Oprah and Serena Williams.
FDA delays Axogen's Avance Nerve Graft BLA review to December 5, after new data submission, while the company raises its full ...
As the HHS and FDA leadership continues to look for ways to boost transparency and reshape the United States' healthcare ...
The Food and Drug Administration approved Papzimeos (zopapogene imadenovec-drba) for the treatment of adults with recurrent ...
Shaman Botanicals has issued a formal response to the FDA’s recent warning letter on its 7-hydroxymitragynine (7-OH) products ...
With the FDA’s go-ahead, Coya plans to launch a multicenter phase 2 trial of COYA 302 in patients with ALS, CEO Arun ...
The FDA classifies this recall as Class II, which the agency describes as a situation "in which use of or exposure to a ...
The FDA is warning consumers not to eat certain frozen shrimp products sold at Walmart after other products from the same ...
The U.S. Food & Drug Administration (FDA) has announced a recall on a limited lot of Blue Bell Ice Cream due to the presence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback